Rating Change
Cantor Fitzgerald reiterated its Overweight rating on MannKind Corporation (NASDAQ:MNKD) on October 20, 2026.
Cantor Fitzgerald reiterated its Overweight rating on MannKind Corporation (NASDAQ:MNKD) on October 20, 2026.

At publication ·
MannKind Corporation (NASDAQ:MNKD) · reiterate
At a glance
Cantor Fitzgerald reiterated its Overweight rating on MannKind Corporation (NASDAQ:MNKD) on October 20, 2026.
MannKind Corporation operates in the Healthcare sector. The stock currently trades at $3.13 with a market capitalization of $1.8B.
Analyst coverage from Cantor Fitzgerald provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for MannKind Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 9 Buy, 1 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 20, 2026 | Cantor Fitzgerald | Overweight | N/A |
| Oct 19, 2026 | Chardan Capital | Buy | N/A |
| Oct 07, 2026 | Truist Securities | Buy | N/A |
| Sep 11, 2026 | Cantor Fitzgerald | Overweight | N/A |
| Aug 06, 2026 | Wells Fargo | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View MNKD Stock Page
A rating of Overweight from Cantor Fitzgerald reflects the analyst's outlook on MannKind Corporation (NASDAQ:MNKD). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the MNKD forecast page.
Current market data
NASDAQ · MNKD
$3.50
Down: -$0.05 · -1.41%
Live quote updated
Keep reading